Consanance

Consanance

Warsaw, Poland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Consonance is a Warsaw-based, privately-held medical device development services company founded in 2020. It operates as a one-stop engineering and regulatory partner for MedTech innovators, offering integrated services across prototyping, hardware engineering, AI integration, certification (e.g., CE, FDA), and manufacturing. With over 100 projects in the last decade, the company has a proven track record in active medical devices and telemedicine, supported by strategic academic partnerships to fuel innovation and talent pipeline. Its business model is service-based, generating revenue from client projects.

AI / Machine LearningDrug Delivery

Technology Platform

Integrated medical device development platform offering hardware engineering, AI/ML integration, drug delivery expertise, regulatory strategy/certification, and small-batch manufacturing as a service.

Opportunities

The growing trend of digital health and AI integration in MedTech creates demand for specialized engineering partners.
Consonance's position in cost-competitive Poland, combined with full-service regulatory expertise, makes it an attractive outsourcing destination for Western startups and corporates.
Strategic academic partnerships provide a pipeline for talent and early-stage innovation.

Risk Factors

Revenue is dependent on a continuous stream of client projects, creating vulnerability to downturns in MedTech startup funding.
Operating as a service provider limits upside from product success and places them in a competitive landscape with other CDDOs.
Inherent technical and regulatory execution risks in complex device development could impact reputation.

Competitive Landscape

Consonance competes with other medical device design and development consultancies (CDDOs), in-house R&D teams at large MedTech firms, and global engineering service providers. Its differentiation lies in its integrated, end-to-end service covering regulatory certification and small-batch manufacturing, its specific AI/drug delivery expertise, and its cost-effective base in Poland with strong academic ties.